Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: Bone-targeted erythrocyte-cancer hybrid membrane-camouflaged nanoparticles for enhancing photothermal and hypoxia-activated chemotherapy of bone invasion by OSCC

Fig. 6

Anticancer efficacy of Asp8[H40-TPZ/IR780@(RBC-H)] NPs in vivo. a Schematic illustration of therapeutic scheme on bone invasion nude mice model. b Photos of WSU-HN6 carcinoma-bearing nude mice. c Tumor photos from each group ex vivo (A: Normal saline, B: Normal saline + Laser, C: TPZ + Laser, D: Asp8[H40-PEG@(RBC-H)] + Laser, E: H40-PEG loading IR780 + Laser, F: H40-TPZ/IR780@(RBC-H) + Laser, and G: Asp8[H40-TPZ/IR780@(RBC-H)] + Laser). d Tumor growth curves of WSU-HN6 tumor-bearing nude mice subjected to various therapy and e the average tumor weight after dissection from each group (n = 5, mean ± SD). **p < 0.01 and *** p < 0.001

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us